An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus
Clinical trial NCT01701063 · TERMINATED
Trial details
- NCT number
- NCT01701063
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2015-04-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.